Annovis Bio raises $6 million in registered direct offering
PositiveFinancial Markets

Annovis Bio has successfully raised $6 million through a registered direct offering, a significant boost for the biotechnology company. This funding is crucial as it will support their ongoing research and development efforts in the healthcare sector, particularly in addressing neurodegenerative diseases. The investment reflects confidence in their innovative approach and could lead to advancements that benefit patients and the industry alike.
— Curated by the World Pulse Now AI Editorial System